Relmada Therapeutics, Inc. — Form D/A
Relmada Therapeutics, Inc. of BLUE BELL, PA, a company, filed a Form D amendment with the SEC on 2013-06-06. The offering totals $8.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-06-06
- Form: D/A
- Accession: 0001213900-13-003005
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $8.0M
- Amount sold: $5.0M
- Remaining: $3.0M
- Minimum investment: $5K
- Investors: 98
- Date of first sale: 2012-07-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-181601
Issuer
- Name: Relmada Therapeutics, Inc.
- CIK: 0001554535
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 146 MEDINAH DRIVE, BLUE BELL, PA, 19422
- Phone: 610-272-2071
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Sergio Traversa | Director | Blue Bell, PA |
| Sergio Traversa | Executive Officer | Blue Bell, PA |
| Nabil M Yazgi | Director | NEW YORK, NY |
| Douglas O Beck | Executive Officer | NEW YORK, NY |
| Shreeram O Agharkar | Director | NEW YORK, NY |
| Sandesh O Seth | Director | NEW YORK, NY |
| Eliseo O Salinas | Executive Officer | NEW YORK, NY |
| Sandesh Seth | Director | NEW YORK, NY |
| Najib Babul | Director | Blue Bell, PA |
| Najib Babul | Executive Officer | Blue Bell, PA |
Other filings by this issuer (3)
More